DK1529040T3 - Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma - Google Patents

Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma

Info

Publication number
DK1529040T3
DK1529040T3 DK03784025T DK03784025T DK1529040T3 DK 1529040 T3 DK1529040 T3 DK 1529040T3 DK 03784025 T DK03784025 T DK 03784025T DK 03784025 T DK03784025 T DK 03784025T DK 1529040 T3 DK1529040 T3 DK 1529040T3
Authority
DK
Denmark
Prior art keywords
derivatives
optionally substituted
use against
against asthma
alkenyloxy
Prior art date
Application number
DK03784025T
Other languages
Danish (da)
English (en)
Inventor
Claudia Eder
Herbert Kogler
Sabine Haag-Richter
Robert Walker Singleton
Arun Subramaniam
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1529040T3 publication Critical patent/DK1529040T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK03784025T 2002-08-02 2003-07-18 Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma DK1529040T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10235624A DE10235624A1 (de) 2002-08-02 2002-08-02 Endiandric acid H und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
DK1529040T3 true DK1529040T3 (da) 2006-05-08

Family

ID=30469404

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03784025T DK1529040T3 (da) 2002-08-02 2003-07-18 Endiandric acid H-derivater som c-maf-inhibitorer til anvendelse mod astma

Country Status (13)

Country Link
US (1) US7019028B2 (fr)
EP (1) EP1529040B1 (fr)
JP (1) JP4598523B2 (fr)
AT (1) ATE314359T1 (fr)
AU (1) AU2003250099B2 (fr)
BR (1) BR0313199A (fr)
CA (1) CA2493483C (fr)
DE (2) DE10235624A1 (fr)
DK (1) DK1529040T3 (fr)
ES (1) ES2254980T3 (fr)
IL (1) IL166439A (fr)
MX (1) MXPA05000387A (fr)
WO (1) WO2004014888A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1944361A1 (fr) 2007-01-11 2008-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthode de propagation de monocytes
ES2911505T3 (es) 2010-10-06 2022-05-19 Inst Catalana Recerca Estudis Avancats Método para el diagnóstico, pronóstico y tratamiento de la metástasis de cáncer de mama
EP2650682A1 (fr) 2012-04-09 2013-10-16 Fundació Privada Institut de Recerca Biomèdica Esters asymétriques d'acides gras utiles en tant que lubrifiants
ES2705237T3 (es) 2012-06-06 2019-03-22 Fundacio Inst De Recerca Biomedica Irb Barcelona Método para el diagnóstico y el pronóstico de metástasis del cáncer de pulmón
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
ES2744244T3 (es) 2012-10-12 2020-02-24 Inbiomotion Sl Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata usando c-MAF
WO2015019125A1 (fr) * 2013-08-05 2015-02-12 Societe De Developpement Et De Recherche Industrielle Cibles moléculaires destinées au traitement des blessures, en particulier des blessures chroniques
CN117230193A (zh) 2016-05-25 2023-12-15 生物运动有限公司 基于c-maf状态的乳腺癌治疗性治疗
EP3713581A1 (fr) 2017-11-22 2020-09-30 Inbiomotion S.L. Traitement thérapeutique du cancer du sein basé sur le c-maf

Also Published As

Publication number Publication date
US7019028B2 (en) 2006-03-28
ATE314359T1 (de) 2006-01-15
DE50302084D1 (de) 2006-02-02
ES2254980T3 (es) 2006-06-16
AU2003250099A1 (en) 2004-02-25
IL166439A0 (en) 2006-01-15
CA2493483C (fr) 2011-09-20
EP1529040A1 (fr) 2005-05-11
AU2003250099B2 (en) 2008-12-18
DE10235624A1 (de) 2004-02-19
JP2006503006A (ja) 2006-01-26
BR0313199A (pt) 2005-06-21
IL166439A (en) 2009-12-24
MXPA05000387A (es) 2005-03-23
JP4598523B2 (ja) 2010-12-15
US20040138313A1 (en) 2004-07-15
CA2493483A1 (fr) 2004-02-19
WO2004014888A1 (fr) 2004-02-19
EP1529040B1 (fr) 2005-12-28

Similar Documents

Publication Publication Date Title
IL166439A0 (en) Endiandric acid derivatives as c-maf inhibitors for using against asthma
NL350075I2 (fr)
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
TW200637559A (en) 3-propenylcefem derivative
DE60130771D1 (de) Substituierte heterocyclische amide
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
CR10499A (es) Profarmaco de compuesto de cinamida
MX2009004910A (es) Compuestos sustituidos de 3-isobutil-9,10-dimetoxi-1,3,4,6,7,11-b- hexahidro-2h-pirido[2,1-a] isoquinolin-2-ol y métodos que se relacionan al mismo.
TW200642683A (en) Heterocyclic compound
MY139461A (en) Condensed furan compounds
PT934928E (pt) Derivados de amina ciclica
EA200701810A1 (ru) Производное изоксазолина и новый способ его получения
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
RS49684B (sr) Upotreba derivata 7-(2-oksa-5,8- diazabiciklo[4.3.0]non-8-il)-hinolon- karbonske kiseline i nafthiridonkarbonske kiseline za pripremanje leka za terapiju helikobakter-pilori infekcija i sa time povezanim gastroduodenalnim oboljenjima
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
ATE402175T1 (de) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
JO2413B1 (en) Benzoxazine derivatives and their use
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
TW200732334A (en) A 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
MY137964A (en) Benzofuran derivative
MXPA05012096A (es) Derivados de amina ciclica, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
EE05136B1 (et) Asendatud imidasopridiinhendite valmistamise meetod
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
WO2010074587A3 (fr) 3-n-aryl-1,3,4-oxadiazolones 5-o-substituées destinées à une utilisation médicale